Overall Trading Platform
Ligand Pharmaceuticals Incorporated (LGND) is a leading biotechnology business based in the US. It opened the day at USD$148.55 after a previous close of USD$146.96. During the day the price has varied from a low of USD$148.55 to a high of USD$152.44. The latest price was USD$150.34 (25 minute delay). Ligand Pharmaceuticals is listed on the NASDAQ and employs 155 staff. All prices are listed in US Dollars.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Since the stock market crash in March caused by coronavirus, Ligand Pharmaceuticals's share price has had significant positive movement.
Its last market close was USD$150.21, which is 32.94% up on its pre-crash value of USD$100.73 and 162.42% up on the lowest point reached during the March crash when the shares fell as low as USD$57.24.
If you had bought USD$1,000 worth of Ligand Pharmaceuticals shares at the start of February 2020, those shares would have been worth USD$787.93 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,677.85.
|52-week range||USD$78.26 - USD$219.75|
|50-day moving average||USD$152.6797|
|200-day moving average||USD$125.9876|
|Wall St. target price||USD$221.14|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$28.289|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-05-05)||15.47%|
|1 month (2021-04-12)||3.75%|
|3 months (2021-02-12)||-12.83%|
|6 months (2020-11-12)||77.16%|
|1 year (2020-05-12)||46.30%|
|2 years (2019-05-10)||29.31%|
|3 years (2018-05-11)||-15.63%|
|5 years (2016-05-12)||28.91%|
Valuing Ligand Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ligand Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ligand Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6975. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ligand Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ligand Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$57.4 million.
The EBITDA is a measure of a Ligand Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$186.4 million|
|Operating margin TTM||15.79%|
|Gross profit TTM||USD$96.6 million|
|Return on assets TTM||1.29%|
|Return on equity TTM||-0.4%|
|Market capitalisation||USD$2.4 billion|
TTM: trailing 12 months
There are currently 1.6 million Ligand Pharmaceuticals shares held short by investors – that's known as Ligand Pharmaceuticals's "short interest". This figure is 4.5% up from 1.5 million last month.
There are a few different ways that this level of interest in shorting Ligand Pharmaceuticals shares can be evaluated.
Ligand Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ligand Pharmaceuticals shares currently shorted divided by the average quantity of Ligand Pharmaceuticals shares traded daily (recently around 182711.05937136). Ligand Pharmaceuticals's SIR currently stands at 8.59. In other words for every 100,000 Ligand Pharmaceuticals shares traded daily on the market, roughly 8590 shares are currently held short.
However Ligand Pharmaceuticals's short interest can also be evaluated against the total number of Ligand Pharmaceuticals shares, or, against the total number of tradable Ligand Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ligand Pharmaceuticals's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Ligand Pharmaceuticals shares in existence, roughly 90 shares are currently held short) or 0.1325% of the tradable shares (for every 100,000 tradable Ligand Pharmaceuticals shares, roughly 133 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Ligand Pharmaceuticals.
Ever wondered how to buy shares in Blue Apron? We explain how and compare a range of providers that can give you access to many brands, including Blue Apron.
Ever wondered how to buy shares in B&G Foods? We explain how and compare a range of providers that can give you access to many brands, including B&G Foods.
Ever wondered how to buy shares in Kandi? We explain how and compare a range of providers that can give you access to many brands, including Kandi.
Ever wondered how to buy shares in Ayro? We explain how and compare a range of providers that can give you access to many brands, including Ayro.
Ever wondered how to buy shares in The Children’s Place? We explain how and compare a range of providers that can give you access to many brands, including The Children’s Place.
Ever wondered how to buy shares in Tanger Factory Outlet Centers? We explain how and compare a range of providers that can give you access to many brands, including Tanger Factory Outlet Centers.
Ever wondered how to buy shares in Blockbuster? We explain how and compare a range of providers that can give you access to many brands, including Blockbuster.
Steps to owning and managing KOSS stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing NAKD stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing BlackBerry stocks, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.